| Product Code: ETC7548709 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neoantigens Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neoantigens Market Revenues & Volume, 2021 & 2031F |
3.3 India Neoantigens Market - Industry Life Cycle |
3.4 India Neoantigens Market - Porter's Five Forces |
3.5 India Neoantigens Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 India Neoantigens Market Revenues & Volume Share, By Therapeutic Specialty, 2021 & 2031F |
3.7 India Neoantigens Market Revenues & Volume Share, By Line of Therapy, 2021 & 2031F |
3.8 India Neoantigens Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 India Neoantigens Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in research and development of personalized medicine |
4.2.3 Rising awareness about the benefits of immunotherapy in cancer treatment |
4.3 Market Restraints |
4.3.1 High costs associated with neoantigen-based therapies |
4.3.2 Regulatory challenges and approval processes for neoantigen therapies in India |
4.3.3 Limited infrastructure and expertise for neoantigen identification and manufacturing |
5 India Neoantigens Market Trends |
6 India Neoantigens Market, By Types |
6.1 India Neoantigens Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 India Neoantigens Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 India Neoantigens Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 India Neoantigens Market Revenues & Volume, By Mono Therapy, 2021- 2031F |
6.2 India Neoantigens Market, By Therapeutic Specialty |
6.2.1 Overview and Analysis |
6.2.2 India Neoantigens Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 India Neoantigens Market Revenues & Volume, By Urinary System Cancer, 2021- 2031F |
6.2.4 India Neoantigens Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.5 India Neoantigens Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.6 India Neoantigens Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.2.7 India Neoantigens Market Revenues & Volume, By Blood and Bone Marrow Cancer, 2021- 2031F |
6.3 India Neoantigens Market, By Line of Therapy |
6.3.1 Overview and Analysis |
6.3.2 India Neoantigens Market Revenues & Volume, By First Line, 2021- 2031F |
6.3.3 India Neoantigens Market Revenues & Volume, By Second Line, 2021- 2031F |
6.3.4 India Neoantigens Market Revenues & Volume, By Later Lines, 2021- 2031F |
6.4 India Neoantigens Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 India Neoantigens Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Neoantigens Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Neoantigens Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 India Neoantigens Market Revenues & Volume, By Others, 2021- 2031F |
7 India Neoantigens Market Import-Export Trade Statistics |
7.1 India Neoantigens Market Export to Major Countries |
7.2 India Neoantigens Market Imports from Major Countries |
8 India Neoantigens Market Key Performance Indicators |
8.1 Percentage increase in clinical trials utilizing neoantigen-based therapies in India |
8.2 Number of collaborations between Indian pharmaceutical companies and global biotech firms for neoantigen research |
8.3 Funding trends in the biotech sector related to neoantigen therapies in India |
9 India Neoantigens Market - Opportunity Assessment |
9.1 India Neoantigens Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 India Neoantigens Market Opportunity Assessment, By Therapeutic Specialty, 2021 & 2031F |
9.3 India Neoantigens Market Opportunity Assessment, By Line of Therapy, 2021 & 2031F |
9.4 India Neoantigens Market Opportunity Assessment, By End users, 2021 & 2031F |
10 India Neoantigens Market - Competitive Landscape |
10.1 India Neoantigens Market Revenue Share, By Companies, 2024 |
10.2 India Neoantigens Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here